Related Experiment Video
Updated: May 27, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
Published on: March 5, 2012
Polyglutamine misfolding in yeast: toxic and protective aggregation
1Boston Biomedical Research Institute, Watertown, MA, USA. duennwald@bbri.org
Abstract:
Protein misfolding is associated with many human diseases, including neurodegenerative diseases, such as Alzheimer disease, Parkinson disease and Huntington disease. Protein misfolding often results in the formation of intracellular or extracellular inclusions or aggregates. Even though deciphering the role of these aggregates has been the object of intense research activity, their role in protein misfolding diseases is unclear. Here, I discuss the implications of studies on polyglutamine aggregation and toxicity in yeast and other model organisms. These studies provide an excellent experimental and conceptual paradigm that contributes to understanding the differences between toxic and protective trajectories of protein misfolding. Future studies like the ones discussed here have the potential to transform basic concepts of protein misfolding in human diseases and may thus help to identify new therapeutic strategies for their treatment.
Insights
Studies on polyglutamine aggregation in model organisms reveal distinct toxic and protective pathways in protein misfolding diseases. This research offers insights into neurodegenerative conditions like Alzheimer's and Parkinson's, potentially guiding new treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Protein misfolding is implicated in numerous human diseases, notably neurodegenerative disorders such as Alzheimer, Parkinson, and Huntington diseases.
- Misfolded proteins often form aggregates, but their precise role in disease pathogenesis remains incompletely understood.
Purpose of the Study:
- To explore the implications of polyglutamine aggregation and toxicity studies in yeast and other model organisms.
- To elucidate the differences between detrimental and beneficial protein misfolding trajectories.
Main Methods:
- Review and synthesis of existing research on polyglutamine aggregation in model organisms.
- Analysis of experimental data from yeast and other model systems to understand protein misfolding.
Main Results:
- Studies in model organisms provide a framework for differentiating between toxic and protective protein misfolding pathways.
- These models highlight the complex nature of protein aggregate formation and its consequences.
Conclusions:
- Understanding protein misfolding trajectories in model organisms is crucial for deciphering human diseases.
- Further research in this area holds promise for developing novel therapeutic strategies for protein misfolding disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Molecular Chaperones and Protein Folding
The...
Protein Folding Quality Check in the RER
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...

